Aardvark Therapeutics (AARD) EPS (Basic) (2024 - 2026)

Aardvark Therapeutics (AARD) reported EPS (Basic) of -$0.99 for Q1 2026, down 40.37% on a YoY basis from -$1.66 in Q1 2025, and down 10.4% sequentially from -$0.9 in Q4 2025.

Aardvark Therapeutics (AARD) EPS (Basic) (2024 - 2026) Analysis & Trends

Aardvark Therapeutics (AARD) has 3 years of EPS (Basic) data on file, last reported at -$0.99 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 40.37% year-over-year to -$0.99; the trailing twelve-month figure through Mar 2026 stood at -$3.2 (down 37.34% YoY), and the FY2025 full-year result was -$3.56, up 63.3% from the prior year.
  • EPS (Basic) eased to -$0.99 in Q1 2026, from -$0.9 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.52 in Q1 2024 to a low of -$2.98 in Q4 2024.
  • A 3-year average of -$1.1 and a median of -$0.9 in 2025 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) jumped 69.94% in 2025 and sank 40.37% in 2026, its largest moves.
  • Tracing AARD's EPS (Basic) over 3 years: stood at -$2.98 in 2024, then soared by 69.94% to -$0.9 in 2025, then retreated by 10.4% to -$0.99 in 2026.
  • Business Quant data shows AARD's EPS (Basic) at -$0.99 in Q1 2026, -$0.9 in Q4 2025, and -$0.75 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Aardvark Therapeutics 139.40 Mn 19.44 Mn - -0.99

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.99
Dec 31, 2025 -0.90
Sep 30, 2025 -0.75
Jun 30, 2025 -0.66
Mar 31, 2025 -0.70
Dec 31, 2024 -2.98
Sep 30, 2024 -1.03
Jun 30, 2024 -1.38
Mar 31, 2024 -0.52